Up 42% since January: Why Merck is defeating the patent cliff

🌐 Investing.com (Cyprus) —
Up 42% since January: Why Merck is defeating the patent cliff

AI Summary

The article says Merck shares have gained 42% since January and examines how the company is managing the threat of a patent cliff. The supplied text gives no further detail about its strategy or financial outlook.

Markets Health Merck pharmaceuticals patent cliff share performance drug patents

Read original source →